Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Nappy rash differential diagnosis

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Unwell infant or destructive eruption

Fever or hypothermia, lethargy, poor feeding, dehydration, rapidly spreading erythema, severe pain, bullae, purpura, necrosis, grouped vesicles in a neonate, urinary obstruction or extensive skin loss suggests sepsis, invasive bacterial disease, neonatal herpes or another serious disorder.

Action: Arrange immediate paediatric assessment, protect temperature and hydration, obtain cultures and viral samples only if they do not delay treatment, and begin age-specific sepsis, antibacterial or antiviral care with safeguarding and infection-control input where indicated.

Synopsis

Distinguish irritant napkin dermatitis from candidal, inflammatory, bacterial and systemic mimics, examine an infant respectfully, use age-safe topical treatment, and escalate persistent or unwell presentations promptly.

  • Irritant napkin dermatitis affects convex surfaces in contact with urine and stool and typically spares the deepest groin folds.
  • Candida produces a confluent red, red-brown or violaceous plaque that involves folds and has satellite papules or pustules beyond the main edge.
  • Seborrhoeic dermatitis reaches folds with greasy scalp, brow or ear scale, while napkin psoriasis is sharply demarcated, smooth and persistent with scale reduced by moisture.
  • In richly pigmented skin, activity may appear dark red, purple, grey-brown or primarily shiny and eroded; warmth, border and fold involvement remain discriminating.
  • First-line irritant care is frequent nappy change, gentle water or fragrance-free cleansing, patting dry, nappy-free air time and a thick barrier at every change.
  • A prescribed mild topical corticosteroid is used briefly for significant sterile inflammation; potent steroid or fixed steroid–antifungal combinations under occlusion can cause systemic and local harm.
  • Use topical antifungal when fold disease and satellites support Candida, while continuing moisture and barrier control; oral antifungal is not routine uncomplicated care.
  • Fiery sharply defined perianal erythema with pain or fissuring raises group-A streptococcal disease, whereas honey crust, blisters or spreading warmth suggests bacterial infection.
  • Persistent erosive or petechial seborrhoeic disease, poor growth, recurrent infection or lesions outside the nappy area should prompt zinc, immune, Langerhans-cell and other systemic assessment.
  • A genital or perianal finding never proves abuse by itself; examine and document with consent, treat the skin disease and use a proportionate safeguarding pathway when history, development or other findings raise concern.

Key red flags

Systemic illness, rapidly advancing inflammation, vesicles in a neonate, purpura, necrosis, severe pain, bleeding, failure to thrive, diarrhoea with periorificial or acral lesions, treatment resistance, hepatosplenomegaly or recurrent unusual infection requires urgent paediatric review.

Neonatal herpetic eruption

Grouped same-sized vesicles, punched-out erosions or crust in a neonate, especially with poor feeding or fever, is an antiviral emergency.

Systemic-disease departure

Petechiae, ulceration, persistent crust, periorificial or acral disease, alopecia, diarrhoea, poor growth or organ enlargement is not routine nappy rash.

Investigation priorities

01
Whole-skin and growth assessmentFirst step

Confirm distribution and identify inflammatory or systemic disease beyond the napkin area.

Management branches

First-line irritant careBreak contact, friction and occlusion

Convex erythema spares folds and the infant is otherwise well.

  1. Change wet or soiled nappies promptly, rinse with lukewarm water and soft material or use fragrance- and alcohol-free wipes when water is impractical, then pat rather than rub dry.
  2. Allow supervised nappy-free time and apply a thick fragrance-free barrier preparation at every change, removing only visible soiling instead of scrubbing all residue away.
  3. Review within several days and add prescribed hydrocortisone 1% briefly when inflammation remains uncomfortable, stopping and reassessing if erosion or spread worsens.
First-line Candida careTreat yeast and its wet habitat

The plaque enters folds and satellite papules or pustules make Candida clinically likely.

  1. Continue frequent changing, gentle drying and barrier protection and check mouth and feeding caregiver for thrush that may need a linked treatment plan.
  2. Apply clotrimazole 1% thinly two or three times daily according to the product and infant plan, separating it from thick barrier application so it reaches skin.
  3. Review adherence and diagnosis if no clear improvement within a week or if disease returns repeatedly, considering bacterial, psoriatic, immune and diabetes contexts.

Key medicines

Hydrocortisone 1% for inflamed napkin skinFor an infant when prescribed, apply a very thin layer once daily to inflamed skin for no more than 7 days, then stop; continue barrier care at separate application times.The nappy acts as occlusion and increases absorption. Avoid untreated infection, ulcerated skin and repeated unsupervised courses; do not use potent products or apply to normal skin, and reassess promptly if the pattern changes.
Clotrimazole 1% creamApply a thin layer two or three times daily to candidal fold and satellite lesions for at least 2 weeks according to the licensed product and clinical response.Stop for marked irritation or allergy, keep away from eyes and avoid assuming every fold rash is fungal. Review recurrent or non-responsive disease for psoriasis, bacterial infection, diabetes, immune disorder or an incorrect application plan.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NHS nappy rashParent-facing prevention, barrier care, treatment thresholds and urgent advice.
  • Primary Care Dermatology Society napkin dermatitisMorphological differential, Candida recognition and treatment sequence.
  • NICE CKS nappy rashAge-specific irritant, corticosteroid, antifungal and referral management.
  • Clotrimazole 1 percent cream SmPCTopical application frequency, duration, excipients and adverse effects.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom